Hindustan Foods Q1 FY27 preview: revenue ₹1,245 cr
Hindustan Foods Ltd
HNDFDS
Ask AI
Stock setup ahead of the results window
Hindustan Foods’ Q1 FY27 results are coming into focus as investors position for the July-August 2026 earnings season. The stock is trading at a CMP of ₹551. The company’s market capitalisation is ₹6,689 crore, while the price-to-earnings multiple is listed as not meaningful.
The near-term attention is on whether the company extends the operating momentum seen through FY26 into the quarter ended June 2026. Estimates in the market are being framed using a trailing-growth approach anchored to last year’s base and recent growth signals.
What the preview is based on
The Q1 FY27 preview referenced here uses a trailing-growth framework applied to Hindustan Foods’ Q1 FY26 base numbers. The Q1 FY26 revenue base is ₹998 crore and net profit was ₹32 crore. The most recent year-on-year growth signal cited is from Q4 FY26.
This matters because it sets an expectation band rather than a single point number. It also helps explain why the revenue and profit estimates are shown as ranges, not a single forecast.
Q1 FY27 estimates: revenue and PAT ranges
Uniresearch’s trailing-growth estimate for Q1 FY27 revenue is ₹1,082-1,245 crore, based on the Q1 FY26 base of ₹998 crore. On profitability, the PAT estimate is ₹37-47 crore versus ₹32 crore in Q1 FY26.
The indicative results date is placed in the July-August 2026 window, aligning with the broader NSE and BSE reporting calendar for the quarter ending June 2026.
Trading levels and the 12-month target range
Hindustan Foods enters the Q1 FY27 results season at ₹551, while the 12-month Uniresearch target range is ₹615-686. The note describes the stance as “tracking with a constructive bias.”
Numerically, that target band sits above the current market price, but it remains a range rather than a single objective. Investors typically watch whether quarterly execution stays consistent with management guidance and whether the margin profile holds up as capacity ramps.
Recent quarterly scorecard: Q1 FY26 versus Q4 FY26
The available quarterly table provides a snapshot of operational movement between the quarter ended June 2025 (Jun 25) and March 2026 (Mar 26). In Jun 25, total revenue was ₹994.69 crore and net income was ₹31.73 crore. In Mar 26, total revenue was ₹1,116.75 crore and net income was ₹41.55 crore.
Operating income is shown at ₹59.09 crore in Jun 25 versus ₹75.87 crore in Mar 26. Total operating expense moved from ₹935.60 crore to ₹1,040.88 crore across the same periods. The table also shows diluted normalized EPS of 2.69 in Jun 25 and 3.49 in Mar 26.
FY26 highlights that frame Q1 FY27 expectations
For FY26, total consolidated income was ₹4,264.69 crore versus ₹3,655.77 crore in FY25, a growth of 16.66% year-on-year. EBITDA for FY26 was ₹377.00 crore, and FY26 PAT was ₹149.03 crore, described as the highest-ever annual PAT.
In Q4 FY26, the company reported total income of ₹1,120.91 crore, EBITDA of ₹104.10 crore, and PAT of ₹41.55 crore. The EBITDA margin for the quarter improved to 9.00% from 8.36% in the year-ago quarter. PBT before exceptional items rose to ₹58.20 crore, and an exceptional item of ₹1.07 crore was recorded, linked to an incremental liability for the Nashik Unit of Avalon Cosmetics on account of business combination.
Capacity build-out and capex plans for FY27
The Board authorised ₹150 crore of investments across three new facilities for FY27, targeting Beverage, Home and Personal Care (HPC), and Ice Cream segments. The specific authorisations cited are ₹50 crore for a bottled water plant in South India, ₹50 crore for ice cream manufacturing in North India, and a previously authorised ₹50 crore detergent bars facility in Lucknow. These are expected to be commercialised by Q3 FY27.
The company also disclosed that projects worth ₹550+ crore have already been commercialised, with the balance targeted for commercialisation in H1 FY27. Gross block is projected to increase from ₹1,810 crore as of March 2026 to ₹2,150 crore by March 2027.
Guidance checkpoints investors may track
Management guidance referenced in the material keeps FY27 PAT in the range of ₹200-220 crore. The company also cited record project wins of ₹780 crore in FY26 and noted two NCLT-approved merger schemes.
Separately, additional operating and balance sheet metrics mentioned include net debt to equity at 0.77x as of December 31, 2025 and annualised adjusted ROCE at 19% after adjusting for CWIP and underutilised assets. These data points can influence how the market interprets growth funded by fresh capex.
Market impact: what could move around Q1 FY27
The immediate market sensitivity is likely to be around whether revenue lands within the ₹1,082-1,245 crore range and whether PAT tracks the ₹37-47 crore estimate band. Another focus area is the pace of commercialisation of the remaining projects targeted for H1 FY27 and the capex-linked commissioning timelines expected by Q3 FY27.
Given the stock’s CMP of ₹551 versus the ₹615-686 12-month target range, incremental information in the results commentary may matter as much as the headline numbers. Investors also tend to watch for any updates that reaffirm the ₹200-220 crore FY27 PAT guidance.
Why the Q1 FY27 print matters
Hindustan Foods ended FY26 with record annual revenue and profit metrics, and the Q4 FY26 quarter was also described as a high watermark for quarterly EBITDA and PAT. Against that backdrop, Q1 FY27 becomes an early read on whether scale benefits and operating leverage continue.
The company’s own commentary highlights “disciplined capital allocation” and “improving operating leverage” as supporting factors. At the same time, it also acknowledged near-term headwinds, making quarterly execution and commissioning progress important reference points.
Conclusion
Hindustan Foods heads into the July-August 2026 reporting window at ₹551, with Q1 FY27 revenue estimated at ₹1,082-1,245 crore and PAT at ₹37-47 crore. FY27 PAT guidance remains ₹200-220 crore, supported by capex plans and ongoing commercialisation of projects. The next clear milestone is the Q1 FY27 results announcement in the indicative July-August 2026 window.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
